Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 3E2.F
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 12.48 2.49 2.21
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 21.57 16.86 13.86
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -23.78 -4.93 -3.98
Cash 4.60 8.81 8.42
Capex 10.86 -0.08 -0.09
Free Cash Flow -75.79 0.50 2.07
Revenue -11.59 5.45 6.17
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 2.00 0.71 0.70
Operating Margin -23.10 0.11 0.14
ROA -18.65 0.03 0.03
ROE 29.52 -0.11 -0.15
ROIC -37.47 0.03 0.05
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 3E2.F is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 3E2.F is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 3E2.F is permitted for members.